ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 79 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $257,363 | -39.4% | 263,989 | -1.7% | 0.13% | -43.1% |
| Q1 2024 | $424,475 | +59.0% | 268,655 | -20.2% | 0.22% | +45.2% |
| Q4 2023 | $266,940 | +8.2% | 336,620 | +6.4% | 0.16% | +2.6% |
| Q3 2023 | $246,734 | -19.0% | 316,325 | -3.9% | 0.15% | -14.7% |
| Q2 2023 | $304,468 | -13.0% | 329,155 | +2.5% | 0.18% | -18.8% |
| Q1 2023 | $350,059 | -19.2% | 321,155 | +8.2% | 0.22% | -25.6% |
| Q4 2022 | $433,240 | -7.6% | 296,740 | -31.9% | 0.29% | -30.9% |
| Q3 2022 | $469,000 | -33.7% | 435,985 | +4.8% | 0.42% | -38.5% |
| Q2 2022 | $707,000 | -18.4% | 416,166 | -1.0% | 0.69% | +0.7% |
| Q1 2022 | $866,000 | -13.2% | 420,447 | +58.0% | 0.68% | -17.0% |
| Q4 2021 | $998,000 | – | 266,048 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $98,493,000 | 3.45% |
| Matrix Capital Management Company, LP | 12,043,511 | $98,636,000 | 3.15% |
| Abingworth LLP | 250,000 | $2,045,000 | 1.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 701,861 | $5,748,000 | 0.94% |
| Rock Springs Capital Management LP | 875,000 | $7,166,000 | 0.33% |
| Tekla Capital Management LLC | 935,368 | $7,661,000 | 0.27% |
| QVT Financial LP | 859,392 | $6,650,000 | 0.25% |
| Orbimed Advisors | 1,914,660 | $15,681,000 | 0.15% |
| Graticule Asia Macro Advisors LLC | 395,824 | $3,242,000 | 0.15% |
| Rathbones Group PLC | 321,050 | $2,629,000 | 0.11% |